TF Gene (Transferrin): Function, Regulation, and Clinical Significance
A comprehensive overview of the transferrin gene (TF), including its genomic context, protein function, expression patterns, associated diseases, and mutation landscape.
Gene Information Card
| Symbol | TF |
|---|---|
| Full Name | Transferrin |
| Gene Type | protein-coding |
| Chromosomal Location | 3q22.1 |
| NCBI Gene ID | 7018 ncbi.nlm.nih.gov/gene/7018 |
| Ensembl ID | ENSG00000091513 |
| UniProt ID | P02787 |
| OMIM ID | 190000 |
| HGNC ID | 11740 |
| Aliases | PRO1557, PRO2086, DKFZp781D0156, MGC38281 |
Description
The TF gene encodes transferrin, a glycoprotein responsible for iron transport in the blood. Transferrin binds ferric iron (Fe3+) with high affinity and delivers it to cells via the transferrin receptor (TFRC). It plays a critical role in iron homeostasis, erythropoiesis, and cellular iron uptake. The protein is primarily synthesized in the liver and secreted into plasma. Mutations in TF can lead to atransferrinemia, a rare autosomal recessive disorder characterized by iron overload in tissues and hypochromic anemia. Additionally, transferrin levels are used clinically as a marker for nutritional status and iron metabolism.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Atransferrinemia | Loss-of-function mutations in TF lead to impaired iron transport, causing iron accumulation in organs (e.g., liver, heart) and iron deficiency in erythroid precursors, resulting in hypochromic microcytic anemia. | OMIM 190000; ClinVar |
| Iron deficiency anemia (secondary) | Reduced transferrin levels or saturation can impair iron delivery to bone marrow, contributing to anemia in chronic disease or malnutrition. | ClinVar; literature |
| Neurodegeneration with brain iron accumulation (NBIA) (possible) | Altered transferrin function may affect brain iron homeostasis, though direct causal evidence is limited. | OMIM; literature |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | ~2000 | High |
| Plasma | N/A | Secreted |
| Bone marrow | Low | Low |
| Brain | Low | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (liver carcinoma) | ~1500 | High expression; used as model for hepatic synthesis |
| K562 (erythroleukemia) | ~200 | Moderate; reflects erythroid lineage |
| HeLa (cervical carcinoma) | ~50 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1429C>T (p.Arg477Ter) | Nonsense | Rare | Loss of function; causes atransferrinemia |
| c.1040G>A (p.Gly347Asp) | Missense | Rare | Impaired iron binding; reduced transferrin function |
| c.179A>G (p.Asn60Ser) | Missense | Rare | Altered glycosylation; may affect protein stability |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations leading to truncated or absent protein, causing atransferrinemia.
Gain of Function (GOF)
No known gain-of-function mutations; transferrin acts as a transporter, and increased function is not associated with pathology.
Dominant Negative (DN)
Not reported; atransferrinemia is autosomal recessive, requiring biallelic loss.
View complete mutation data:
Gene Ontology (GO)
| • iron ion binding | • ferric iron binding |
| • metal ion binding | • extracellular space |
| • blood microparticle | • iron ion transport |
| • cellular iron ion homeostasis | • receptor-mediated endocytosis |
Pathways
• Iron metabolism
• Transferrin endocytosis and recycling
• Hepcidin-ferroportin regulation
Protein Summary
Transferrin is a 79 kDa glycoprotein with two homologous lobes (N- and C-lobe), each capable of binding one ferric ion. It undergoes conformational changes upon iron binding and release, facilitating iron delivery via transferrin receptor-mediated endocytosis. The protein is essential for iron transport and is involved in cellular proliferation, differentiation, and immune responses. Post-translational modifications include glycosylation, which affects stability and function.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| TFEB Knockout KGN Cell Line | EDJ-KQ49 | Human | 7942 | Details Get a Quote |
| TFDP1 Knockout HEK293 Cell Line | EDJ-KQ409 | Human | 7027 | Details Get a Quote |
| TFG Knockout HEK293 Cell Line | EDJ-KQ950 | Human | 10342 | Details Get a Quote |
| TFRC Knockout HEK293 Cell Line | EDC08077 | Human | 7037 | Details Get a Quote |
| TFE3 Knockout HEK293 Cell Line | EDC90423 | Human | 7030 | Details Get a Quote |
| TFF3 Knockout HEK293 Cell Line | EDJ-KQ3912 | Human | 7033 | Details Get a Quote |
| TFAP2A Knockout HEK293 Cell Line | EDJ-KQ5917 | Human | 7020 | Details Get a Quote |
| TFAP2B Knockout HEK293 Cell Line | EDJ-KQ5918 | Human | 7021 | Details Get a Quote |
| TFAP2C Knockout HEK293 Cell Line | EDJ-KQ5919 | Human | 7022 | Details Get a Quote |
| TFCP2 Knockout HEK293 Cell Line | EDJ-KQ5920 | Human | 7024 | Details Get a Quote |
| TFDP2 Knockout HEK293 Cell Line | EDJ-KQ5921 | Human | 7029 | Details Get a Quote |
| TFF1 Knockout HEK293 Cell Line | EDJ-KQ5922 | Human | 7031 | Details Get a Quote |
| TFR2 Knockout HEK293 Cell Line | EDJ-KQ5925 | Human | 7036 | Details Get a Quote |
| TFF2 Knockout HEK293 Cell Line | EDJ-KQ5927 | Human | 7032 | Details Get a Quote |
- 1
- 2
- Next Page »